Potential surrogate endpoints for overall survival (OS) in immunotherapy (IO)-treated metastatic renal cell carcinoma (mRCC): An International Metastatic Database Consortium (IMDC) study

被引：0

作者：

Saliby, R. M. ^{[1
]}

Xie, W. ^{[2
]}

Wells, J. C. ^{[3
]}

Saad, E. ^{[1
]}

Eid, M. ^{[1
]}

Semaan, K. ^{[1
]}

Labaki, C. ^{[4
]}

Ferrier, E. ^{[5
]}

Zarba, M. ^{[5
]}

Ebrahimi, H. ^{[6
]}

Suarez Rodriguez, C. ^{[7
]}

Ruiz, J. M. ^{[8
]}

Powles, T. B. ^{[9
]}

Wood, L. A. ^{[10
]}

De Velasco Oria, G. A. ^{[11
]}

Takemura, K. ^{[12
]}

Braun, D. A. ^{[13
]}

Heng, D. Y. C. ^{[14
]}

Choueiri, T. K. ^{[1
]}

机构：

[1] Dana Farber Canc Inst, Med Oncol, Boston, MA 02115 USA

[2] Dana Farber Canc Inst, Dept Data Sci, Boston, MA 02115 USA

[3] BC Canc Agcy, Med Oncol, Vancouver, BC, Canada

[4] Dana Farber Canc Inst, Med Genet Unit, Boston, MA 02115 USA

[5] Tom Baker Canc Clin, Med Oncol, Calgary, AB, Canada

[6] City Hope Comprehens Canc Ctr, Med Oncol, Duarte, CA USA

[7] Vall dHebron Univ Hosp, Oncol Dept, Barcelona, Spain

[8] Ipsen Mexico S RL CV, Med Oncol, Mexico City, DF, Mexico

[9] Barts Hlth NHS Trust, St Bartholomews Hosp, Oncol Dept, London, England

[10] Dalhousie Univ, Div Med Oncol, Dept Med, Halifax, NS, Canada

[11] Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain

[12] JFCR, Canc Inst Hosp, Genitourinary Oncol, Koto Ku, Tokyo, Japan

[13] Yale Univ, Sch Med, Yale Canc Ctr, Ctr Mol & Cellular Oncol, New Haven, CT USA

[14] Tom Baker Canc Clin, Oncol Dept, Calgary, AB, Canada

来源：

ANNALS OF ONCOLOGY | 2024年 / 35卷

关键词：

D O I：

10.1016/j.annonc.2024.08.1797

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1704P

引用

页码：S1021 / S1022

页数：2

共 50 条

[1] Sites of metastasis and survival in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC)
Dudani, Shaan
de Velasco, Guillermo
Wells, Connor
Gan, Chun Loo
Donskov, Frede
Porta, Camillo
Fraccon, Anna
Pasini, Felice
Hansen, Aaron Richard
Bjarnason, Georg A.
Beuselinck, Benoit
Pal, Sumanta K.
Hotte, Sebastien J.
Lalani, Aly-Khan A.
Yuasa, Takeshi
Kanesvaran, Ravindran
Reaume, M. Neil
Canil, Christina M.
Choueiri, Toni K.
Heng, Daniel Yick Chin
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
[2] Sites of metastasis and survival in metastatic renal-cell carcinoma (mRCC): Resuits from the international mRCC Database Consortium (IMDC)
Dudani, Shaan
de Velasco, Guillermo
Wells, J. Connor
Gan, Chun Loo
Donskov, Frede
Porta, Camillo
Fraccon, Anna
Pasini, Felice
Hansen, Aaron
Bjarnason, Georg
Beuselinck, Benoit
Pal, Sumanta K.
Hotte, Sebastien
Lalani, Aly-Khan A.
Yuasa, Takeshi
Kanesvaran, Ravindran
Reaume, M. Neil
Canil, Christina
Choueiri, Toni K.
Heng, Daniel Y. C.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 : 4 - 4
[3] Evaluating intermediate endpoints (IE) for overall survival (OS) in metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (ICI): An IMDC study.
Saliby, Renee Maria
Xie, Wanling
Wells, J. Connor
Saad, Eddy
Eid, Marc
Labaki, Chris
Semaan, Karl
Ferrier, Evan
Lemelin, Audreylie
Suarez, Cristina
Ruiz-Morales, Jose Manuel
Powles, Thomas
Wood, Lori
Ebrahimi, Hedyeh
de Velasco, Guillermo
Takemura, Kosuke null
Agarwal, Neeraj
Braun, David A.
Heng, Daniel Yick Chin
Choueiri, Toni K.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 400 - 400
[4] Third line therapy in metastatic renal cell carcinoma (mRCC): results from the international mRCC database consortium (IMDC)
Stukalina, Igor
Wellsa, J. Connor
Donskovb, Frede
Rinic, Brian I.
Leed, Jae-Lyun
Bjarnasone, Georg A.
Beuselinckf, Benoit
Smoragiewicz, Martin
Alvah, Ajjai Shivaram
Srinivasi, Sandy
Woodi, Lori
Saleemk, Sadia
Pal, Sumanta Kumar
Yuasam, Takeshi
Broomn, Reuben James
Kanesvaran, Ravindran
Bamiasp, Aristotelis
Knoxq, Jennifer J.
Henga, Daniel Y. C.
Choueirir, Toni K.
BJU INTERNATIONAL, 2015, 116 : 21 - 21
[5] Third-line therapy in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC)
Heng, Daniel Yick Chin
Stukalin, Igor
Wells, Connor
Donskov, Frede
Rini, Brian I.
Lee, Jae-Lyun
Bjarnason, Georg A.
Beuselinck, Benoit
Smoragiewicz, Martin
Alva, Ajjai Shivaram
Srinivas, Sandy
Wood, Lori
Brugarolas, James
Pal, Sumanta Kumar
Yuasa, Takeshi
Broom, Reuben James
Kanesvaran, Ravindran
Bamias, Aristotelis
Knox, Jennifer J.
Choueiri, Toni K.
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[6] Fourth-Line Therapy in Metastatic Renal Cell Carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC)
Stukalin, Igor
Wells, J. Connor
Fraccon, Anna
Pasini, Felice
Porta, Camillo
Lalani, Aly-Khan A.
Srinivas, Sandy
Bowman, I. Alex
Brugarolas, James
Lee, Jae-Lyun
Donskov, Frede
Beuselinck, Benoit
Bamias, Aristotelis
Rini, Brian, I
Sim, Hao-Wen
Agarwal, Neeraj
Rha, Sun-Young
Kanesvaran, Ravindran
Choueiri, Toni K.
Heng, Daniel Y. C.
KIDNEY CANCER, 2018, 2 (01) : 31 - 36
[7] The very favorable metastatic renal cell carcinoma (mRCC) risk group: Data from the International Metastatic RCC Database Consortium (IMDC).
Schmidt, Andrew Lachlan
Xie Wanling
Gan, Chun Loo
Wells, Connor
Dudani, Shaan
Donskov, Frede
Porta, Camillo
Suarez, Cristina
Szabados, Bernadett
Wood, Lori
Ruiz Morales, Jose Manuel
Tran, Ben
Bjarnason, Georg A.
Yuasa, Takeshi
Beuselinck, Benoit
Hansen, Aaron Richard
Agarwal, Neeraj
Bakouny, Ziad
Heng, Daniel Yick Chin
Choueiri, Toni K.
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
[8] Evaluating intermediate endpoints for overall survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors: an IMDC study
Saliby, Renee Maria
Xie, Wanling
Wells, Connor J.
Saad, Eddy
Eid, Marc
Semaan, Karl
Labaki, Chris
Ferrier, Evan
Zarba, Martin
Ebrahimi, Hedyeh
Ravi, Praful
Suarez, Cristina
Morales, Jose Ruiz
Mckay, Rana R.
Powles, Thomas
Wood, Lori
Lalani, Aly-Khan A.
Pal, Sumanta K.
de Velasco, Guillermo
Takemura, Kosuke
Agarwal, Neeraj
Braun, David A.
Heng, Daniel Y.
Choueiri, Toni K.
ONCOLOGIST, 2024, 29
[9] First-line sunitinib versus pazopanib in metastatic renal cell carcinoma (mRCC): Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
Morales, Jose Manuel Ruiz
Wells, J. Connor
Donskov, Frede
Bjarnason, Georg A.
Lee, Jae-Lyun
Knox, Jennifer J.
Beuselinck, Benoit
Vaishampayan, Ulka N.
Brugarolas, James
Broom, Reuben James
Bamias, Aristotelis
Yuasa, Takeshi
Srinivas, Sandhya
Ernst, D. Scott
Pezaro, Carmel Jo
Wood, Lori
Kollmannsberger, Christian K.
Rini, Brian I.
Choueiri, Toni K.
Heng, Daniel Yick Chin
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
[10] Fourth-line targeted therapy in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC).
Stukalin, Igor
Wells, Connor
Fraccon, Anna Paola
Pasini, Felice
Porta, Camillo
Moreira, Raphael Brandao
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)

← 1 2 3 4 5 →